Clinical Trials Directory

Trials / Completed

CompletedNCT02845622

Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity

Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity in Healthy Subjects: A Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Ospedale San Donato · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study aims to assess the effects of hazelnuts, cocoa, and the combination of both on vascular reactivity and metabolic profile. Participants, divided in six groups, will receive one of these breakfast integrations for 14 days: group 1) 30 g peeled hazelnuts; group 2) 30 g unpeeled hazelnuts; group 3) snack with 30 g peeled hazelnuts; group 4) snack with 2.5 g cocoa powder; group 5) snack with 30 g peeled hazelnuts and 2.5 g cocoa; group 6) empty snack, control group.

Detailed description

In the last few years, the prevalence of overweight and obesity has increased in all age groups. The European Food Safety Authority stated "cocoa flavanols help maintain endothelium-dependent vasodilation, which contributes to normal blood flow". Several studies reported that a daily consumption of hazelnuts reduces the risk of cardiovascular disease. The hypothesis of this study is to demonstrate a beneficial effect of hazelnut and cocoa diet integrations on vascular reactivity and endocrine-metabolic parameters.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHazelnutThis dietary supplement contains 30 g of hazelnut.
DIETARY_SUPPLEMENTCocoaThis dietary supplement contains 2.5 g of cocoa powder.
DIETARY_SUPPLEMENTNo hazelnuts / No cocoaThis dietary supplement does not contain hazelnut nor cocoa powder.
DIETARY_SUPPLEMENTCreamThis dietary supplement is just a cream obtained by grinding hazelnuts.
DIETARY_SUPPLEMENTSnackThis dietary supplement is a commercial snack containing either hazelnut or cocoa or both.

Timeline

Start date
2014-06-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2016-07-27
Last updated
2016-09-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02845622. Inclusion in this directory is not an endorsement.